CASE REPORT
CLOVES syndrome caused by mosaic mutation in the PIK3CA gene identified in fibroblasts
1
Wroclaw Medical University, Poland
2
Medical University of Warsaw, Poland
Submission date: 2021-02-18
Final revision date: 2021-03-14
Acceptance date: 2021-03-20
Publication date: 2021-07-01
Pediatr Pol 2021;96(2):148-152
KEYWORDS
TOPICS
ABSTRACT
CLOVES syndrome is a rare dysmorphic syndrome with multiple defects caused by somatic activating mutations in the PIK3CA gene on chromosome 3q26.32. There are currently less than 200 individuals worldwide living with CLOVES syndrome (OMIM: 612918, ORPHA: 140944). Due to the extremely low prevalence rate of CLOVES syndrome, few epidemiological data are available in the literature. We report 4-year-old girl with somatic mutation in the PIK3CA gene (c.1357G> A) in fibroblast, revealed in the WES study, confirming the diagnosis of CLOVES syndrome. CLOVES syndrome can be very difficult to diagnose, not only because of its extreme rarity, but also due to symptoms which vary both in range of symptoms and severity. Therefore, the case described by us may be helpful in the correct diagnosis of this rare disease in subsequent cases and makes an important contribution in rare disease diagnostics.
REFERENCES (17)
2.
Sapp JC, Turner JT, van de Kamp JM, et al. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A 2007; 143A: 2944-2958.
5.
Kurek KC, Luks VL, Ayturk UM, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90: 1108-1115.
6.
Nathan N, Keppler-Noreuil KM, Biesecker LG, et al. Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway. Dermatol Clin 2017; 35: 51-60.
7.
Uller W, Fishman SJ, Alomari AI. Overgrowth syndromes with complex vascular anomalies. Semin Pediatr Surg 2014; 23: 208-215.
8.
Mirzaa G, Conway R, Graham JM Jr, et al. PIK3CA-Related Segmental Overgrowth. 2013 Aug 15. In: Adam MP, Ardinger HH, Pagon RA, et al. (ed.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
9.
Sarici D, Akin MA, Kurtoglu P, et al. A Neonate with CLOVES Syndrome. Case Rep Pediatr 2014; 2014: 845074.
10.
Mahajan VK, Gupta M, Chauhan P, et al. Cloves Syndrome: A Rare Disorder of Overgrowth with Unusual Features – An Uncommon Phenotype? Indian Dermatol Online J 2019; 10: 447-452.
11.
Alomar S, Khedr RE, Alajlan S. CLOVES Syndrome in a Nine-month-old Infant. Cureus. 2019; 11: e5772.
12.
Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167A: 287-295.
13.
Chang F, Liu L, Fang E, et al. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel. J Mol Diagn 2017; 19: 613-624.
14.
Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 2018; 558: 540-546.
15.
López Gutiérrez JC, Lizarraga R, Delgado C, et al. Alpelisib Treatment for Genital Vascular Malformation in a Patient with Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) Syndrome. J Pediatr Adolesc Gynecol 2019; 32: 648-650.
16.
Gustin JP, Cosgrove DP, Park BH. The PIK3CA gene as a mutated target for cancer therapy. Curr Cancer Drug Targets 2008; 8: 733-740.
17.
Madsen RR, Vanhaesebroeck B, Semple RK. Cancer-Associated PIK3CA Mutations in Overgrowth Disorders. Trends Mol Med 2018; 24: 856-870.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
